Stratégies thérapeutiques dans le cancer bronchique non à petites cellules ALK positif de stade IV
Sign Up to like & getrecommendations! Published in 2019 at "Revue Des Maladies Respiratoires"
DOI: 10.1016/j.rmr.2019.02.008
Abstract: Anaplastic lymphoma kinase (ALK) rearrangement is a therapeutically targetable oncogenic driver found in 5% of patients with non-small-cell lung cancer (NSCLC). The objective of this paper is to synthesise current knowledge on ALK rearrangement and… read more here.
Keywords: alk; gies rapeutiques; dans cancer; cancer ... See more keywords